Arctic Bioscience AS (ABS.OL)

NOK 1.9

(-5.0%)

Total Liabilities Summary of Arctic Bioscience AS

  • Arctic Bioscience AS's latest annual total liabilities in 2023 was 41.69 Million NOK , up 3.15% from previous year.
  • Arctic Bioscience AS's latest quarterly total liabilities in 2023 FY was 41.69 Million NOK , up 3.15% from previous quarter.
  • Arctic Bioscience AS reported annual total liabilities of 40.42 Million NOK in 2022, up 93.22% from previous year.
  • Arctic Bioscience AS reported annual total liabilities of 20.92 Million NOK in 2021, down -28.5% from previous year.
  • Arctic Bioscience AS reported quarterly total liabilities of - NOK for 2023 Q1, down -100.0% from previous quarter.
  • Arctic Bioscience AS reported quarterly total liabilities of 41.69 Million NOK for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Arctic Bioscience AS (2023 - 2018)

Historical Annual Total Liabilities of Arctic Bioscience AS (2023 - 2018)

Year Total Liabilities Total Liabilities Growth
2023 41.69 Million NOK 3.15%
2022 40.42 Million NOK 93.22%
2021 20.92 Million NOK -28.5%
2020 29.26 Million NOK 57.56%
2019 18.57 Million NOK -21.03%
2018 23.51 Million NOK 0.0%

Peer Total Liabilities Comparison of Arctic Bioscience AS

Name Total Liabilities Total Liabilities Difference
Aqua Bio Technology ASA 15.72 Million NOK -165.179%
ArcticZymes Technologies ASA 30.02 Million NOK -38.861%
BerGenBio ASA 46.85 Million NOK 11.022%
Hofseth BioCare ASA 348.97 Million NOK 88.052%
PCI Biotech Holding ASA 5 Million NOK -732.555%
Thor Medical ASA 58.91 Million NOK 29.224%
Ultimovacs ASA 69.64 Million NOK 40.136%